-
-
Odgovor korisniku/ci @Steve_382
My gut feeling is the bar is set very high by
$JNJ +$ARWR in treating HBV. Other companies might not have ability to meet their current safety and efficacy standards. Just my thoughts, not trying to be controversial. Don’t shoot me for them.0 proslijeđenih tweetova 9 korisnika označava da im se sviđa
Odgovor korisnicima @1243MN21t @Steve_382
I’m leery of an HBV-ASO treatment dosed more frequently/maybe at higher concentrations than RNAi-based HBV Drug. $SBPH IRIG dosed orally 400mg-D might have been to strong for patients w hepatic decompensation. I’m no expert, just my thoughts.
16:19 - 29. sij 2020.
0 replies
0 proslijeđenih tweetova
1 korisnik označava da mu se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.